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Cesarean sectionAbstract Background: Spinal anesthesia has many advantages for cesarean section parturients, but
hypotension is considered the most frequent complication and can be managed by different interven-
tions. One of these interventions is to give a serotonin receptor antagonist prior to spinal anesthesia.
Objectives: To compare between two serotonin receptor antagonists on the hemodynamics, sensory,
and motor blockade induced by intrathecal bupivacaine in parturients undergoing cesarean section.
Patients and methods: Sixty patients undergoing elective cesarean section under spinal anesthesia by
intrathecal bupivacaine were randomly divided into three groups (20 pregnant females of ASA I–II
physical status in each group). Group O received intravenous 4 mg ondansetron diluted in 10 ml nor-
mal saline and injected over 1 min, 5 min before spinal anesthesia, group G given intravenous 1 mg
granisetron by the same route and group S given 10 ml normal saline. Mean arterial blood pressure,
heart rate, vasopressor use, sensory, and motor blockade were assessed.
Results: Decreases in mean arterial pressure were signiﬁcantly lower in group O than groups G and
S with lower vasopressor use (P< 0.05), while there was signiﬁcant faster sensory recovery in group
G than groups O and S (P< 0.05). Actually, there were signiﬁcant decrease in the incidence of nau-
sea in groups O and G than group S (P= 0.008).
Conclusion: In parturient females undergoing elective cesarean section, intravenous 4 mg ondanse-
tron before subarachnoid block signiﬁcantly decreased both the hypotension and the doses of vaso-
370 M.M. Rashad, M.S. Farmawypressor used, while intravenous 1 mg granisetron prior to subarachnoid block induced faster sensory
recovery compared to both the ondansetron and the saline groups, with no signiﬁcant differences
between the later two groups.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
Open access under CC BY-NC-ND license.1. Introduction
Many anesthetists prefer to give spinal anesthesia for women
who will undergo cesarean section due to many advantages like
avoiding risks of general anesthesia, for better postoperative
pain relief and also for keeping the woman awake to see her
baby just after birth [1]. Although this can be achieved by spinal
or epidural anesthesia, spinal anesthesia is a simple technique
with low failure rate, rapid onset, and low drug dose [2].
On the other hand, the anesthetist is facing certain prob-
lems after giving spinal anesthesia like hypotension, bradycar-
dia, and failure of block. But hypotension represents incidence
of about 55–100%, so it is the most frequent complication
[3,4]. Moreover, hypotension is hazardous for the mother
and the baby as it can cause loss of consciousness, aspiration,
and even cardiac arrest for the mother and placental hypoper-
fusion, which can lead to fetal problems [5].
There are several methods to minimize maternal hypoten-
sion after spinal anesthesia like ﬂuids, medications, and phys-
ical methods like positioning, leg bindings, etc. [1].
This study concentrated on two medications, which can
minimize the occurrence of maternal hypotension after spinal
anesthesia. They are ondansetron and granisetron selective 5-
hydroxytryptamine 3 (5-HT3) receptor antagonists [6]. These
receptors are located peripherally as cardiac chemoreceptors
on the cardiac vagal afferent and centrally in the chemoreceptor
trigger zone [7]. On the other hand, the Bezold–Jarisch reﬂex
(BJR) is one of the mechanisms, which explain the occurrence
of hypotension after spinal anesthesia through serotonin with
decreased blood volume [7–10]. Stimulation of cardiac chemo-
receptors in the heart by decreased venous return increases the
parasympathetic activity, while it decreases the sympathetic
activity resulting in vasodilatation and bradycardia [11].
Moreover, 5-HT3 receptors are present also in the spine
and have antinociceptive effect, which can be antagonized by
selective 5-HT3 receptor antagonist [12].
On the other hand, previous studies proved that the level of
serotonin increased signiﬁcantly in cerebrospinal ﬂuid after
intrathecal bupivacaine, and the sensory block of intrathecal
lidocaine was antagonized by ondansetron [13,14].
The aim of this study was to compare the effects of the two
serotonin receptor antagonists ondansetron and granisetron
on the spinal induced hypotension, bradycardia, sensory, and
motor block after intrathecal hyperbaric bupivacaine in par-
turients undergoing cesarean sections.
2. Patients and methods
After approval of the medical ethics committee and obtaining
written consent from each patient, this comparative study was
conducted in Zagazig University Surgical Hospitals. Sixty preg-
nant women, ASA I–II physical status, aged from 20 to 40 years
scheduled for elective cesarean section were included in this
prospective study. Women with contraindication for neuraxialblock (like disturbed hemodynamics, coagulation defects,
history of hypersensitivity to granisetron or local anesthetic
agents, hypertensive disorders of pregnancy, cardiovascular
insufﬁciency, on selective serotonin reuptake inhibitors or
migraine medications) or patient refusal were excluded from
the study. All patients were requested during the preanesthetic
visit to be fasting 6–8 h preoperatively. Before the spinal block
noninvasive blood pressure (BP), pulse rate and pulse oximetry
(SPO2) readings were recorded, and a peripheral 18-gauge i.v.
cannula was inserted. All patients received i.v. ranitidine
(1 mg/kg) and preload with lactated Ringer’s solution 20 mL/
kg/h given over 30 min.
Patients were randomly divided into three equal groups
containing twenty patients each. Group O received 4 mg
ondansetron diluted in 10 ml of normal saline intravenously,
group G received intravenous 1 mg granisetron diluted in
10 ml of normal saline, and group S received intravenous
10 ml normal saline injected over 1 min, 5 min before starting
the subarachnoid block.
In the operating room, baseline values of noninvasive blood
pressure (BP), electrocardiogram (ECG), and pulse oximetry
(SPO2) were recorded. The 10 ml solution (ondansetron, gra-
nisetron, or saline) was given intravenously; then 5 min later,
spinal anesthesia was done for the patient in the sitting posi-
tion at the level of L3–4 or L4–5 by injection of 2 ml 0.5%
hyperbaric bupivacaine (Marcaine, AstraZeneca, So¨derta¨lje,
Sweden) intrathecal through a 25-gauge Quincke needle after
cerebrospinal ﬂuid free ﬂow without barbotage, and then, pa-
tients placed in the supine position with left lateral tilt by 15.
Intravenous lactated Ringer’s solution was infused at 15 ml/
kg/h till the end of surgery.
A resident anesthesiologist blinded to the study drug solu-
tions measured and recorded the haemodynamics, presence
of nausea, vomiting, shivering, or inadequate analgesia.
Mean Arterial Pressure (MAP), heart rate (HR), and oxy-
gen saturation (SPO2) were recorded from the starting of
spinal anesthesia at 2-min interval for 20 min then every
5 min till the end of operation.
Moreover, the upper sensory level was assessed using a
short beveled 25-gauge needle by bilateral loss of pinprick at
the midclavicular line every 2 min till the ﬁxation of the sen-
sory level at two consecutive times, and this is the maximum
sensory level; then, the patients were evaluated every 15 min
till sensory level regression to S1.
Also, motor block was assessed every 2 min by the modiﬁed
Bromage scale till the complete motor block then every 15 min
till complete motor recovery.
Modiﬁed Bromage scale [15]:
 0 = able to move hip, knee, ankle, and toes.
 1 = unable to move hip, able to move knee, ankle, and
toes.
 2 = unable to move hip and knee, able to move ankle and
toes.
 3 = unable to move hip, knee and ankle, able to move toes.
ynamic changes 371 4 = unable to move hip, knee, ankle and toes.Figure 1 Changes in Mean Arterial Pressure (MAP) in the 3
groups.Decrease in MAP more than 20% of the preoperative value
was treated with i.v. 6 mg ephedrine.
Decrease in HR to less than 50 beat/min was treated with
0.5 mg atropine intravenous.
Shivering was treated with i.v. 25 mg tramadol.
Nausea and vomiting were treated with i.v. 10 mg
metoclopromide.
Pain was treated with i.v. 50 lg fentanyl, but if persisted, it
was considered failed spinal anesthesia, and patient anesthe-
tized generally and excluded from the study.
2.1. Statistical analysis
Data were checked, entered and analyzed by using (SPSS ver-
sion 19). Data were expressed as mean ± SD for quantitative
variables, number and percentage for categorical variables
Chi-squared (v2) or ﬁsher exact test, ANOVA (F test) and
LSD (when ANOVA was signiﬁcant) for comparison in be-
tween groups. P< 0.05 was considered statistically signiﬁcant.
3. Results
In the present study, there were no signiﬁcant differences be-
tween the two groups as demographic data (age, weight, and
height) and the procedure duration regards (Table 1).
There were nonsigniﬁcant differences among the groups as
regard the basal MAP and HR (See Fig. 1) and (Table 2).
But as regards the decrease in MAP, there was signiﬁcant
difference between group O and both groups G and S at 5,
10, 15, 20, and 25 min. While there was insigniﬁcant differences
between groups G and S, after 25 min, there was nonsigniﬁcant
differences among the three groups (see Table 2 and Fig. 1).
There were no signiﬁcant differences in HR among the
three groups.
There was no signiﬁcant difference of the time of ﬁxation of
sensory level among the three groups (See Table 3).
On the other hand, there were two signiﬁcant segments
regression in group G faster than both groups S and O
(64 ± 20 vs 80 ± 24 min and 73 ± 27 min, respectively) (Ta-
ble 3). Also, regression to T10, T12, and S1 was faster in group
G than groups O and S, but no signiﬁcant differences found
between groups O and S (Table 3).
Also in (Table 3), there were no signiﬁcant differences
among the three groups in the time to maximum motor block,
time to motor recovery by one level, and the time to complete
motor recovery.
Effects of intravenous ondansetron and granisetron on hemodTable 1 Demographic data and procedure duration.
Age (yr) Height (cm)
Group O (n= 20) 32 ± 5 167 ± 5
Group G (n= 20) 30 ± 5 165 ± 5
Group S (n= 20) 31 ± 7 167 ± 6
P value 0.56 0.45
Data represented by mean ± SD.
No signiﬁcant differences between the 3 groups.
Group O = Ondansetron.
Group G=Granisetron.
Group S = Saline.Oxygen saturation did not change signiﬁcantly in all
groups.
There were no statistically signiﬁcant differences in occur-
rence of shivering, pain, or bradycardia (Table 4). But 10% of
patients in group S and 15% of patients in group G suffered
from bradycardia and treated by atropine (0.5 mg can be re-
peated every 3–5 min if needed to amaximal total dose of 3 mg).
Although no patient in all groups suffered from vomiting,
there was signiﬁcant increase in the number of cases experienced
nausea in group S more than groups G and O (40% vs 10% and
5%, respectively), but no signiﬁcant differences found between
groups G and O. Moreover, there was signiﬁcant increase in
the use of ephedrine in groups S and G more than group O
(35% and 25% vs 5%, respectively) (Table 4).
There were two cases of failed spinal anesthesia anesthe-
tized generally and excluded from the study.
4. Discussion
Spinal anesthesia is one of the regional techniques commonly
used with cesarean section parturients to avoid most of risks
which can happen with general anesthesia [2]. But that tech-
nique carries some risks also: the most common risk is hypo-
tension due to almost complete sympathetic block as the
level of block must be to T4 for adequate coverage plus the ef-
fect of gravid uterus on the venous return [2,16,17].
Several studies were done in a trial to prevent undesired
cardiovascular effects of spinal anesthesia like hypotension,
which is considered one of the most risky effects [2]. But in this
study, comparison done between two strong antiemetic medi-
cations which are ondansetron and granisetron as regard their
effects on blood pressure changes, sensory, and motor block of
spinal anesthesia given to C.S. parturients as both medications
have the same mechanism of action.Weight (kg) Procedure duration (min)
79 ± 10 63 ± 7
75 ± 11 63 ± 9
74 ± 13 60 ± 8
0.43 0.47















100 ± 10 82 ± 12 84 ± 4 84 ± 4 92 ± 6 93 ± 5
Group G
(n= 20)
98 ± 10 75 ± 8* 74 ± 9* 78 ± 3* 86 ± 6* 87 ± 6*
Group S
(n= 20)
99 ± 8 80 ± 12* 82 ± 6* 80 ± 5* 90 ± 9* 90 ± 8*
P value 0.8 0.03 0.02 0.001 0.002 0.013
Data represented by mean ± SD and numbers.
Group O= Ondansetron.
Group G=Granisetron.
Group S = Saline.
* Compared with group O (P< 0.05).
Table 3 Spinal block timing course.
Group O Group G Group S P value
Time to upper sensory level block (min) 12.1 ± 2.3 11.2 ± 2.9 11.9 ± 3.8 0.6
Time to two segment regression (min) 72.8 ± 17.1* 64.3 ± 20.2 79.8 ± 23.5* 0.05
Time to sensory regression to T10 (min) 102.9 ± 25.0* 98.2 ± 21.1 115.7 ± 20.1* 0.037
Time to sensory regression to T12 (min) 126.2 ± 26.3* 107.8 ± 18.6 124.8 ± 15.6* 0.007
Time to sensory regression to S1 (min) 181 ± 31.9* 159.8 ± 21.4 179.5 ± 24.6* 0.005
Time to modeﬁed Bromage scale = 4 (min) 10.1 ± 1.9 10.9 ± 2.0 9.8 ± 1.8 0.2
Time to modeﬁed Bromage scale = 3 (min) 113.4 ± 21.9 109.3 ± 27.2 119.0 ± 15.1 0.5
Time to modeﬁed Bromage scale = 0 (min) 168.2 ± 28.4 159.5 ± 33.8 170.2 ± 25.4 0.32
Data represented by mean ± SD.
Group O= Ondansetron.
Group G=Granisetron.
Group S = Saline.
* Signiﬁcant compared with group G (P< 0.05).
Table 4 Incidence of side effects of the spinal anesthesia in the 3 groups.
Shivering N (%) Pain N (%) Nausea N (%) Bradycardia N (%) Ephedrine use N (%)
Group O (n= 20) 2 (10.0) 2 (10.0) 1 (5.0*) 0 (0.0) 1 (5.0*)
Group G (n= 20) 2 (10.0) 3 (15.0) 2 (10.0*) 3 (15.0) 5 (25.0)
Group S (n= 20) 5 (25.0) 3 (15.0) 8 (40.0) 2 (10.0) 7 (35.0)
P value 0.3 0.86 0.008 0.21 0.05
Data represented as number and percentage.
Group O= Ondansetron.
Group G=Granisetron.
Group S = Saline.
* Signiﬁcant compared with S (P< 0.05).
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lar resistance and so pooling of blood and hypotension. BJR
triggered by heart mechanoreceptors results in the systemic re-
sponse to hyper and hypovolemia [18–20]. So, serotonin-in-
duced BJR participates in the systemic response to spinal
anesthesia by vasodilatation, hypotension, and bradycardia
[10,21].
Ondansetron is one of the medications studied before by
Sahoo et al. [22] and proved that it attenuated spinal induced
hypotension if given intravenously in C.S. patients beforespinal anesthesia, and our results coincided with their ﬁnd-
ings. On the other hand, Tsikouris et al. [23] in their study
on granisetron found that it decreased heart rate and BP
changes occurred during the head-up tilt table test due to
BJR and that study encouraged the authors of the present
study to compare between it and ondansetron as regard their
hemodynamic effects on C.S. parturients under spinal anes-
thesia. But, it was found that granisetron had no effects on
the hemodynamic variables, and this is in agreement with
Mowaﬁ et al. [12].
Effects of intravenous ondansetron and granisetron on hemodynamic changes 373Animal studies clariﬁed that serotonin has antinociceptive
effect at the spinal cord level by inhibiting the excitatory trans-
mitters and increasing the inhibitory transmitters [24,25]. Con-
sequently, serotonin antagonists decreasing the nociceptive
threshold as proved by Giordano and Dyche [26].
When the effects of ondansetron and granisetron on sensory
regression and motor block of subarachnoid anesthesia were
studied, it was found that IV ondansetron did not affect sensory
or motor block of intrathecal bupivacaine the same as Samra et
al. proved in their study [27] but against the results of Fas-
soulaki et al. [14], who found that systemic ondansetron en-
hance the sensory block regression after intrathecal lidocaine.
Conversely, in this study, we found that IV granisetron prior
to intrathecal bupivacaine resulted in faster sensory regression
but no effect on the motor block .That results agreed with
Mowaﬁ et al. [12] who studied the effects of IV granisetron
on the sensory and motor blockade produced by intrathecal
bupivacaine and with Fassoulaki et al. [14] who studied the ef-
fects of IV ondansetron on the spinal anesthesia with lidocaine.
These differences between the effects of ondansetron and
granisetron although both of them from the same category
and the same mechanism of action may be due to the action
of ondansetron on mixed receptors and the high selectivity
of granisetron on 5-HT3 receptors but minimal afﬁnity of it
for other 5-HT receptors, adrenergic, histaminic, dopaminer-
gic, or opioid receptors [6,28].
5. Conclusion
It is concluded that in parturient females undergoing elective
cesarean section, intravenous 4 mg ondansetron before
subarachnoid block signiﬁcantly decreased both the hypoten-
sion and the doses of vasopressor used, while intravenous
1 mg granisetron prior to subarachnoid block induced faster
sensory recovery compared to both the ondansetron and saline
groups, with no signiﬁcant differences between the later two
groups.
Limitations in this study included not comparing different
doses of both medications and not comparing ondansetron
with commonly used vasopressors to evaluate which is beneﬁ-
cial for patients especially because of the higher cost of seroto-
nin receptors antagonists. Other studies recommended to
evaluate whether the spinal bupivacaine dose must be adjusted
in patients treated with granisetron due to the possibility of its
reversal of perioperative analgesia.
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